The evolution of botulinum neurotoxin type A for cosmetic applications

By Carruthers Jean   Carruthers Alastair  

Journal of Cosmetic and Laser Therapy, Vol. 9, Iss. 3, 2007-01 ,pp. : 186-192

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial

By Shikiar Richard   Heffernan Michael   Langley Richard   Willian Mary   Okun Martin   Revicki Dennis  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 25-31

Informa Healthcare

Access to resources Recommend Favorite

Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis

By Revicki Dennis   Willian Mary Kaye   Menter Alan   Gordon Kenneth   Kimball Alexa   Leonardi Craig   Langley Richard   Kimel Miriam   Okun Martin  

Journal of Dermatological Treatment, Vol. 18, Iss. 6, 2007-01 ,pp. : 341-350

Informa Healthcare

Access to resources Recommend Favorite

Facial rejuvenation with botulinum neurotoxin: An anatomical and experiential perspective

By Fagien Steven   Raspaldo Hervé  

Journal of Cosmetic and Laser Therapy, Vol. 9, Iss. 1, 2007-09 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids

By De Boulle Koen  

Journal of Cosmetic and Laser Therapy, Vol. 10, Iss. 2, 2008-01 ,pp. : 87-92

Informa Healthcare

Access to resources Recommend Favorite